• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1996 Fiscal Year Final Research Report Summary

Clinical application of seminal plasma sperm motility inhibitor.

Research Project

Project/Area Number 06454461
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionSt.Marianna University School of Medicine

Principal Investigator

IWAMOTO Teruaki  St.Marianna Univ., Urology, Professor., 医学部, 教授 (60046117)

Co-Investigator(Kenkyū-buntansha) FURUICHI Yasuhiro  AGENE Research institute, Director, 所長
TANAKA Hiroki  St.Marianna Univ., Urology, Instructor, 医学部, 助手 (00217069)
Project Period (FY) 1994 – 1996
KeywordsSeminal plasma sperm motility inhibitor / Seminal vesicle / Seminal plasma / Asthenozoospermia / Dynein arm / Semenogelin / basic protein / Sperm adhesin family
Research Abstract

1. We described the primary structure of SPMI,the coding of boar SPMI cDNA gene, Nucleotide sequence analysis of the 645-bp SPMI cDNA predicts a coded polypeptide of 137 amino acid residues which includes a 21-residue signal peptide and a 116 residues secreted protein. The amino acid sequence of SPMI was found to be highly homologous to AQN-3, a member of spermadhesin family proteins of boar that bind to spermatozoa. Expression of the boar SPMI gene detected by Northern blot analysis revealed that its expression is very abundunt in seminal vesicles and specific to this tissue.
2. When SPMI was reacted with normal motile sperm, the motility was inhibited in a dose-dependent manner, and completely suppressed at a SPMI concentration of 1500U/ml. After immediate washing of the immotilized sperm, they resumed movement and recovered 30% motility. However, motility was not recovered at a SPMI concentration of 2000U/ml or more. The mechanism of the inhibition of sperm motility was immunohistochemically examined at electron microscopic level using anti-boar SPMI antibody. SPMI was stained on the surface cell membrane of sperm and not stained on inside cell. SPMI did not penetrate the sperm cell membrane. These findings suggest that sperm can not move physically by the attachment of SPMI to cell membrane or second messenger from the sperm cell membrane attached with SPMI inhibits the activity of dynein ATPase.
3. Human SPMI precursor identifies with Semenogelin I,II.We investigated whether gene structure of Semenogelin I,II on infertile patients is different with that on fertile men. Two infertile patients and one fertile man had a deletion of same size, 180bp of Semenogelin I DNA.This deletion of gene was not specific in infetile patients.

  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] 田中宏樹: "清漿中に存在する精子運動抑制因子の基礎的研究-新しい精製法と精子運動に対する可逆性について-" 聖マリアンナ医科大学雑誌. 23. 972-982 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Iwamoto et al.: "Cloning of boar SPMI gene which is expected specifically in seminal vesicle and codes for a sperm motility inhibitor protein." FEBS Letters. 368. 420-424 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 東海林洋子、嶋田甚五郎: "オリゴヌクレオチドのDDS." 臨床薬理の進歩. 16. 9-19 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shoji Y.,Shimada J,.et al.: "Cellular uptake and biological effects of antisense oligodeoxynucleotides analogs targeted to herpes simplex virus." Antimicrob.Agents Chem.40. 1670-1675 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岩谷若夫、東海林洋子、田村信也、乗松美貫、嶋田甚五郎、水島裕: "抗HSV活性を有するアンチセンス・オリゴDNAの安定性およびウイスル感染細胞における動態の検討。" Drug Delivery System. 11. 427-434 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Shoji,J.Shimade,et al.: "Anti-HIV activity of phosphorothioate oligodeoxynucleotides containing consecutive G sequences" Int.J.Immunotherapy. XII(1/2). 1-9 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Shoji,Shimade,et al.: "Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol." Drug Targeting. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 東海林洋子、松原司、大内信香、舟橋恵子、嶋田甚五郎、水島裕: "VEGF mRNAに対するアンチセンスDNAのヒトさい帯静脈の管腔形成抑制効果をカチオン性リポソームが増強。" Drug Delivery System. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.Tanaka: "Sperm motility inhibitor from boar seminal plasma. -A modification of the purification methods of the inhibitor and the reversibility of sperm motile action" St.Marianna Med.J.23. 972-982 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Iwamoto Y.Furuichi et al.: "Cloning of boar SPMI gene which is expected specifically in seninal vesicle and codes for a sperm motility inhibitor protein." FEBS Letters. 368. 420-424 (1995)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi